Table 1.
Characteristics of patients hospitalized with COVID-19 and discharged alive who consented to follow up interview.
| Value | |
|---|---|
| Total, N | 456 |
| Female, N (%) | 168 (36.8%) |
| Age, mean (SD) | 59.4 (14.1) |
| Age, range ( N , %) | |
| 18–44 | 62 (13.6%) |
| 45–64 | 225 (49.3%) |
| ≥65 | 169 (37.1%) |
| Ethnicity, N (%) | |
| Caucasian | 377 (87.7%) |
| Other | 53 (12.3%) |
| Comorbidities, N (%) | |
| Respiratory diseases | 52 (11.7%) |
| Cardiovascular diseases | 188 (42.2%) |
| Nephropathies | 16 (3.4%) |
| GI diseases and hepatopathies | 37 (8.3%) |
| Rheumatological diseases | 10 (2.3%) |
| Metabolic diseases | 81 (18.2%) |
| Neurologic diseases | 20 (4.5%) |
| Cancer | 16 (3.6%) |
| SOT and HSCT | 5 (1.1%) |
| Number of comorbidities, N (%) | |
| 0 | 176 (40.4%) |
| 1–2 | 197 (45.2%) |
| ≥3 | 63 (14.5%) |
| Symptoms at COVID-19 onset, N (%) | |
| Respiratory symptoms | 364 (80.4%) |
| Systemic symptoms* | 412 (90.4%) |
| Neurologic symptoms | 64 (14.4%) |
| GI symptoms | 85 (18.8%) |
| Number of symptoms at COVID-19 onset, median (IQR) | 3 (2–4) |
| Hospitalization length, median (IQR) | 12 (6–21) |
| Hospitalization length, N (%) | |
| <14 days | 242 (53.1%) |
| ≥14 days | 214 (46.9%) |
| ICU admission, N (%) | 46 (10.4%) |
| Destination after discharge, N (%) | |
| Home | 378 (84.4%) |
| Rehab facility/Long-term care | 70 (15.6%) |
| Complications during hospital stay, N (%) | 250 (55.0%) |
| Severity scale, N (%) | |
| 1 (H, no oxygen required) | 136 (30.2%) |
| 2 (H, O2 max Venturi Mask) | 224 (49.7%) |
| 3 (H, HFNC or CPAP or NIV) | 91 (20.2%) |